Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C27H24Cl2N4O5 |
| Molecular Weight | 555.409 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)C1=CC2=C(C=C1)N(C)C(=O)N(C2=O)C3=CC=C(C[C@H](NC(=O)C4=C(Cl)C=CC=C4Cl)C(O)=O)C=C3
InChI
InChIKey=YQKBOUPIOWUMTE-NRFANRHFSA-N
InChI=1S/C27H24Cl2N4O5/c1-31(2)17-11-12-22-18(14-17)25(35)33(27(38)32(22)3)16-9-7-15(8-10-16)13-21(26(36)37)30-24(34)23-19(28)5-4-6-20(23)29/h4-12,14,21H,13H2,1-3H3,(H,30,34)(H,36,37)/t21-/m0/s1
| Molecular Formula | C27H24Cl2N4O5 |
| Molecular Weight | 555.409 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Carotegrast is phenylalanine derivative patented by pharmaceutical company Ajinomoto Co. for the treatment or prevention of inflammatory disease states related to the α4 integrin-dependent adhesion process. In preclinical studies, Carotegrast shows pharmacological activity in rheumatoid arthritis and inflammatory bowel disease.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:46:09 GMT 2025
by
admin
on
Mon Mar 31 18:46:09 GMT 2025
|
| Record UNII |
Y1HYC6SO3F
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
401904-75-4
Created by
admin on Mon Mar 31 18:46:09 GMT 2025 , Edited by admin on Mon Mar 31 18:46:09 GMT 2025
|
PRIMARY | |||
|
C169828
Created by
admin on Mon Mar 31 18:46:09 GMT 2025 , Edited by admin on Mon Mar 31 18:46:09 GMT 2025
|
PRIMARY | |||
|
DTXSID00193188
Created by
admin on Mon Mar 31 18:46:09 GMT 2025 , Edited by admin on Mon Mar 31 18:46:09 GMT 2025
|
PRIMARY | |||
|
300000036888
Created by
admin on Mon Mar 31 18:46:09 GMT 2025 , Edited by admin on Mon Mar 31 18:46:09 GMT 2025
|
PRIMARY | |||
|
Y1HYC6SO3F
Created by
admin on Mon Mar 31 18:46:09 GMT 2025 , Edited by admin on Mon Mar 31 18:46:09 GMT 2025
|
PRIMARY | |||
|
10120218
Created by
admin on Mon Mar 31 18:46:09 GMT 2025 , Edited by admin on Mon Mar 31 18:46:09 GMT 2025
|
PRIMARY | |||
|
9224
Created by
admin on Mon Mar 31 18:46:09 GMT 2025 , Edited by admin on Mon Mar 31 18:46:09 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PRODRUG -> METABOLITE ACTIVE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|